Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1448218

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1448218

Global Neurology Devices Market Size, Share, Growth Analysis, By Product(Neurostimulation Devices, Neurosurgery Devices), By End User(Hospitals, Neurology Clinics) - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Neurology Devices Market size was valued at USD 14.58 Billion in 2022 and is poised to grow from USD 15.76 Billion in 2023 to USD 29.39 Billion by 2031, at a CAGR of 8.1% during the forecast period (2024-2031).

Numerous neurological conditions, including epilepsy, traumatic brain damage, spinal cord injury, Parkinson's disease, and Alzheimer's disease, are the focus of neurology devices, which are designed to identify, prevent, and cure these conditions. In order to improve patient outcomes and the quality of life for individuals with neurological illnesses, the neurology device is essential. The purpose of this gadget is to give medical practitioners cutting-edge instruments and technologies for the diagnosis and treatment of neurological conditions. These tools support therapeutic intervention, help identify anomalies, and track the course of the condition. In addition to facilitating early diagnosis and treatment, these technologies enhance patient care and yield superior clinical results.

The market is expanding as a result of the rising incidence of neurological disorders and the increased demand for early diagnosis. The need for neurological devices is growing due to the increased prevalence of epilepsy and stroke. Furthermore, there is a growing need for efficient diagnostic and therapeutic approaches that improve patient outcomes. The expensive nature of neurological devices and the strict requirements for obtaining regulatory clearances further impede market expansion.

Additionally, the industry is growing due to technological advancements and innovative medical device companies. As a medical practitioner and researcher, you should always be researching new medical devices because there is a growing need for advanced equipment that improve patient outcomes and provide precise diagnoses. The government's initiative to expand the medical device industry, the rise in finances for the construction of healthcare facilities, and the expansion of research and development activities in the medical device sector all contribute to the growth of the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurology Devices Market Beverage Packaging Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neurology Devices Market Segmental Analysis

The product, end user, and geographic segments of the worldwide neurology devices market are separated out. The market is divided into product categories, including cerebrospinal fluid devices, neurosurgical devices, neurostimulation devices, and interventional neurology devices. The market is divided into ambulatory care centers, neurology clinics, and hospitals based on the end user. The market is divided into Latin America, Middle East and Africa, Asia Pacific, North America, and Europe.

Drivers of the Global Neurology Devices Market

The need for neurology devices is still being driven by the rising incidence of neurological conditions like epilepsy, Parkinson's disease, and Alzheimer's disease. The World Health Organization (WHO) states that millions of individuals worldwide suffer from neurological illnesses, which calls for cutting-edge treatment and diagnostic options.

Restraints in the Global Neurology Devices Market

The market for neurology devices is subject to stringent regulations, which include gaining permission from regulatory bodies like the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). For smaller producers, complying with these laws can be difficult and expensive, which could impede the expansion of the industry.

Market Trends of the Global Neurology Devices Market

Transition to Less Invasive Techniques In the discipline of neurology, there is a discernible shift toward minimally invasive methods. Benefits of minimally invasive procedures include fewer surgical problems, shorter hospital stays, and faster recuperation periods. The need for neurological devices that allow for precise manipulations with less tissue injury is being driven by this trend.

Product Code: SQMIG35A2500

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Neurology Devices Market by Product

  • Market Overview
  • Neurostimulation Devices
  • Neurosurgery Devices
  • Interventional Neurology Devices
  • Cerebrospinal Fluid Devices
  • and Others

Global Neurology Devices Market by End User

  • Market Overview
  • Hospitals
  • Neurology Clinics
  • and Ambulatory Care Centers

Global Neurology Devices Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Medtronic (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zimmer Biomet Holdings, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nihon Kohden Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hitachi, Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Brainlab AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elekta AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nevro Corp. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Natus Medical Incorporated (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Penumbra, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integra LifeSciences Holdings Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neuropace, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!